Calithera Biosciences, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CALA research report →
About the company
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business.
- CEO
- Stephanie Wong
- IPO
- 2014
- Employees
- 8
- HQ
- South San Francisco, CA, US
Price Chart
- Market Cap
- $1.95K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 0.62
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -131.13%
- ROIC
- -184.41%
- Revenue
- $0 · -100.00%
- Net Income
- $-18,866,000 · 83.61%
- EPS
- $-7.94 · 74.52%
- Op Income
- $-42,074,000
- FCF YoY
- 34.17%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -1.37
- Avg Volume
- 467
Get TickerSpark's AI analysis on CALA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 17, 23 | TAKEDA PHARMACEUTICAL CO LTD | other | 1,000,000 |
| Jan 27, 23 | PAKIANATHAN DEEPIKA | sell | 1,172 |
| Jan 23, 23 | Sjogren Eric | other | 279 |
| Jan 23, 23 | Kuriakose Emil | other | 79 |
| Jan 23, 23 | Molineaux Susan | other | 526 |
| Jan 23, 23 | Wong Stephanie | other | 317 |
| Jan 23, 23 | Molineaux Christopher | other | 217 |
| Jul 1, 22 | Takeda Ventures, Inc. | other | 1,000,000 |
| Jul 1, 22 | TAKEDA PHARMACEUTICAL CO LTD | other | 1,000,000 |
| Jul 1, 22 | Takeda Ventures, Inc. | other | 1,000,000 |
Our CALA coverage
Recent articles, reports, and earnings notes.
No research on CALA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CALA report →Similar companies
Peers in the same neighborhood.